Latest Period
Q4 2025
Security Snapshot
PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) Institutional Ownership
CUSIP: 70387R403
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
27
Shares (Excl. Options)
1,917,493
Price
$0.22
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- PAVM on Nasdaq
- Shares outstanding
- 6,367,621
- Price per share
- $0.24
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,917,493
- Total reported value
- $426,481
- % of total 13F portfolios
- 0%
- Share change
- +382,415
- Value change
- +$27,422
- Number of holders
- 27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 70387R403.
- 27 institutions reported positions in Q4 2025.
- 9 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 27 to 0 between Q4 2025 and Q1 2026.
- Reported value moved from $426,481 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 27 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 70387R403?
CUSIP 70387R403 identifies PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 70387R403:
Significant Owners of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 9.9% | $858,421 | 1,226,316 | Ayrton Capital LLC | 31 Dec 2024 | |||
| Sargent Investment Group, LLC | 5.8% | $604,183 | 1,006,300 | Sargent Investment Group, LLC | 01 Jul 2025 | |||
| Tasso Partners, LLC | 15% | -19% | $215,114 | -$353,303 | 974,246 | -62% | Dana Carrera | 27 Mar 2026 |
| FIRST MANHATTAN CO. LLC. | 4.3% | $499,870 | 714,100 | FIRST MANHATTAN CO. LLC. | 31 Mar 2025 | |||
| Scopia Holdings LLC | 9.9% | $140,798 | 637,670 | Matthew Sirovich | 27 Mar 2026 | |||
| NAGELBERG DAVID S | 8.6% | $120,770 | 546,964 | NAGELBERG DAVID S | 27 Mar 2026 | |||
| Kallman Craig | 6% | $84,923 | 384,616 | Kallman Craig | 27 Mar 2026 | |||
| Aklog Lishan | 5.1% | $81,490 | 369,068 | Aklog Lishan | 02 Apr 2026 | |||
| Dols Scott V. | 5.4% | $76,431 | 346,155 | Dols Scott V. | 27 Mar 2026 |
As of 31 Dec 2025, 27 institutional investors reported holding 1,917,493 shares of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM). This represents 30% of the company’s total 6,367,621 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) together control 30% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FIRST MANHATTAN CO. LLC. | 11% | 714,100 | 0% | 0% | $157,673 |
| VANGUARD GROUP INC | 5.4% | 342,171 | +64% | 0% | $75,620 |
| UBS Group AG | 3.5% | 219,813 | +25195% | 0% | $48,579 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 168,832 | +75% | 0% | $39,848 |
| NORTHERN TRUST CORP | 1.7% | 107,279 | +131% | 0% | $23,687 |
| BlackRock, Inc. | 1.1% | 72,425 | -0.32% | 0% | $15,991 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.1% | 68,210 | 0% | $15,061 | |
| GSA CAPITAL PARTNERS LLP | 1% | 65,903 | 0% | $15,000 | |
| LPL Financial LLC | 0.87% | 55,566 | +0.06% | 0% | $12,269 |
| XTX Topco Ltd | 0.66% | 41,717 | +239% | 0% | $9,211 |
| STATE STREET CORP | 0.33% | 20,854 | 0% | 0% | $4,605 |
| StoneX Group Inc. | 0.19% | 12,303 | 0% | $2,717 | |
| XML Financial, LLC | 0.16% | 10,067 | 0% | 0% | $2,223 |
| MORGAN STANLEY | 0.08% | 4,826 | -4% | 0% | $1,066 |
| CWM, LLC | 0.07% | 4,672 | -27% | 0% | $1,000 |
| Tower Research Capital LLC (TRC) | 0.07% | 4,368 | -0.41% | 0% | $964 |
| WELLS FARGO & COMPANY/MN | 0.03% | 1,644 | 0% | 0% | $363 |
| SIMPLEX TRADING, LLC | 0.02% | 1,048 | 0% | $231 | |
| CIBC Private Wealth Group LLC | 0.01% | 836 | 0% | 0% | $185 |
| JONES FINANCIAL COMPANIES LLLP | 0% | 246 | 0% | 0% | $54 |
| BANK OF AMERICA CORP /DE/ | 0% | 216 | +65% | 0% | $48 |
| Allworth Financial LP | 0% | 161 | -45% | 0% | $36 |
| Federation des caisses Desjardins du Quebec | 0% | 95 | 0% | 0% | $20 |
| OSAIC HOLDINGS, INC. | 0% | 81 | 0% | 0% | $16 |
| BNP PARIBAS FINANCIAL MARKETS | 0% | 30 | 0% | 0% | $7 |
Institutional Holders of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$2,223 | $0.24 | 0 |
| 2025 Q4 | 1,917,493 | $426,481 | +$27,422 | $0.22 | 27 |
| 2025 Q3 | 1,535,145 | $662,767 | +$133,813 | $0.43 | 32 |
| 2025 Q2 | 1,224,831 | $735,397 | +$3,569 | $0.60 | 29 |
| 2025 Q1 | 1,211,515 | $873,492 | +$123,620 | $0.72 | 30 |
| 2024 Q4 | 1,041,798 | $653,834 | -$49,628 | $0.63 | 25 |
| 2024 Q3 | 1,120,689 | $1,378,717 | +$95,825 | $1.23 | 22 |
| 2024 Q2 | 1,056,670 | $861,151 | +$57,582 | $0.82 | 23 |
| 2024 Q1 | 952,389 | $2,032,208 | +$362,293 | $2.14 | 22 |
| 2023 Q4 | 753,692 | $3,104,938 | +$3,104,938 | $4.12 | 25 |